Riyadh – Mubasher: Lana Medical Company announced that its ordinary general assembly (OGM) resulted in the rejection of a board recommendation to distribute cash dividends for the 2025 fiscal year, according to a bourse filing.

The proposed distribution totaled SAR 1.62 million, representing SAR 0.03 per share or 3% of the company's SAR 54 million capital.

The meeting, held on 30 June 2026, saw shareholders approve the appointment of RSM Allied Accountants Professional Services to audit financial statements for the second (Q2), third (Q3), and annual periods of 2026, and Q1-27, for a fee of SAR 355,000.

Additionally, the assembly approved the payment of SAR 195,000 in remuneration to board and committee members for the 2025 fiscal year.

Shareholders also discharged the board of directors from liability for the same period and reviewed the annual financial statements and auditor's report.

The meeting was chaired by Dr. Mohammed bin Abdullah Al Sheiha with the presence of several board and committee heads.